FRAMINGHAM, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of six abstracts for ePoster presentation at the 20th German Allergy Congress taking place in Düsseldorf, Germany from October 2–4, 2025. Details are as follows: Thursday, October 2 at 4:00–5:15 pm CEST: Time to End of Progression of Hereditary Angioedema Attacks … [Read more…]

ATLANTA–(BUSINESS WIRE)–Mirion Technologies, Inc. (“Mirion”) (NYSE: MIR), today announced the pricing of an underwritten public offering of 17,309,846 shares of Mirion’s Class A common stock at a public offering price of $21.35 per share (the “common stock offering”). The size of the common stock offering was increased from the previously announced $350.0 million of shares … [Read more…]

TOKYO–(BUSINESS WIRE)–Kirin Holdings Company, Limited (Kirin) (TOKYO: 2503) has developed a seedling cultivation technology that enhances heat and drought tolerance in hops through acquired tolerance, helping to address the growing challenges of reduced yield and quality caused by extreme heat and drought. This method enables hops to gain resilience without compromising flavor quality, and is … [Read more…]

80s Week Returns with Two National Sweepstakes and an Exclusive LA Celebration IRVINE, Calif.–(BUSINESS WIRE)–Each September, Club Pilates studios across the U.S. and Canada turn up the neon and crank the volume for the brand’s beloved 80s Week Event. This year, the brand is taking the celebration to new heights, inviting its community across the … [Read more…]

DALLAS–(BUSINESS WIRE)–Healthmine, a leading member engagement and rewards platform for health plans, today announced that its Board of Directors has appointed Dwight Erskine as its new Chief Executive Officer, effective September 15, 2025. Erskine succeeds Bryce Williams, who will remain with the company during a transition period before moving into an advisory role. Erskine joins … [Read more…]

WINNIPEG, Manitoba–(BUSINESS WIRE)–The Bioscience Association Manitoba (BAM) marked Global Biotech Week 2025 with a special proclamation ceremony at the Manitoba Legislative Building today. The event brought together students, industry leaders, and government representatives to celebrate Manitoba’s growing contributions to the bioscience sector. During the ceremony, Manitoba’s commitment to innovation, collaboration, and education in bioscience was … [Read more…]

ADALAT® XL® (nifedipine extended-release tablets) first received market authorization in Canada in 1995 and is indicated for the management of chronic stable angina and the management of mild to moderate essential hypertension. MISSISSAUGA, Ontario–(BUSINESS WIRE)–Bayer Canada is pleased to announce a new partnership with Mint Pharmaceuticals Inc. for the distribution of ADALAT® XL® 30 mg … [Read more…]

Eight in 10 adults agree that adult smokers should have access to smoke-free options, while 76% worry that decisions are based on ideology rather than science and facts STAMFORD, Conn.–(BUSINESS WIRE)–A new international survey conducted by Povaddo and commissioned by Philip Morris International Inc. (NYSE: PM) reveals strong global support for smoke-free alternatives to cigarettes … [Read more…]

– Partner Curasense will market Equazen® products featuring a clinically researched combination of essential fatty acids across pharmacies, healthcare stores and online pharmacies. LUGANO, Switzerland–(BUSINESS WIRE)–#GLAsupplements–SFI Health™ EMEA, the regional entity of SFI Health™, a global leader in natural healthcare, and Curasense BV (Curasense), a Belgian company specializing in the distribution and development of high-quality … [Read more…]

FRAMINGHAM, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (“KalVista”) (NASDAQ: KALV), announced today the pricing of its offering of $125.0 million aggregate principal amount of 3.250% Convertible Senior Notes due 2031 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of … [Read more…]